SBIR/STTR Research Award

Enzyme Based Reporter Probes of Signal Transduction

Award identifier 13179e24ff3205f8a5b1d610b263dd51a49ef507aafcd513e33ac99a6f4f4e2cAwarding agency Department of Health and Human Services

Award amount

$78,966

Program and phase

SBIR · Phase I

Award year

1994

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
NUTRIMED BIOTECH
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

The phosphoinositide-specific phospholipase C (PI-PLC) and the phosphatidylinositol 3-kinase (PI3-kinase) are key enzymes in the intracellular signal transduction pathway. These enzymes utilize thephosphoinositides, in particular phosphatidylinositol-4,5-bisphosphate [PI (4,5)P2] as substrate.Stimulated hydrolysis of PI (4,5)P2 by PI-PLC generates the two second messengers inositol-1,4,5-trisph-osphate (IP3) and sn-1,2-diacylglycerol (DAG) which are implicated in many physiological responsesincluding mitogenesis. PI 3-kinase associates with and is phosphorylated by activated growth factorreceptors and oncogene products which manifest protein-tyrosine kinase activity. It phosphorylatesPI(4,5)P2 specifically at the D-3 hydroxyl to produce PI(3,4,5)P3 which is the putative novel and criticalsecond messenger of growth signals. The overall objective is to develop novel biochemical probes ofmammalian PI-PLC and PI 3-kinase, based on structural analogues of the phosphoinositides carryingreporter groups. During Phase I, the molecular design, synthesis, and characterization of a novel set ofconjugands capable of linking with reporter groups will be addressed. In addition, prototype photoaffinityprobes will be prepared. These probes will be evaluated as substrates and inhibitors in preliminaryassays in collaborative studies with other laboratories. During Phase II, the design of the probes willrefined and studies on PI-PLC and PI 3-kinase will be extended to identify the substrate binding andcatalytic domains, to trace the downstream targets of P 3-kinase products, and to develop substrateanalogues and inhibitors suitable for application in structure-based small molecule drug development.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.